Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

Audio By Carbonatix

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Sep 30, 2025--

Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consumer applications — and arrive during a milestone year of unprecedented growth and innovation.

Breakthrough AI Innovation Drives Market Leadership

The recognition comes as Komodo accelerates its market leadership through breakthrough AI innovation. The company recently launched Marmot™, the industry's first healthcare-native AI engine, which fundamentally transforms how organizations generate insights from healthcare data. Unlike foundational AI models adapted for healthcare use, Marmot was engineered specifically for healthcare and Life Sciences workflows with deep domain expertise, advanced analytics, and healthcare-specific reasoning capabilities.

Built on Komodo's Healthcare Map ®, which captures insights from over 330 million de-identified U.S. patients, Marmot delivers transparent, verifiable insights in minutes rather than weeks, enabling critical decisions across the entire product life cycle, from clinical trial design to post-market evidence generation.

Expanding Impact Across Healthcare and Beyond

Komodo’s influence extends well beyond traditional healthcare boundaries. The company powered more than 250 peer-reviewed studies and 31 presentations at ISPOR 2025, demonstrating the scientific rigor and real-world impact of its healthcare analytics AI platform. Additionally, Komodo is advancing healthcare insights for Financial Services through a groundbreaking partnership with Nasdaq while broadening strategic alliances with leading technology innovators, including Databricks and Snowflake.

“These recognitions reflect our team’s dedication to building healthcare analytics AI the right way — leveraging decades of domain expertise and 11 years of executing on our full stack thesis, spanning our Healthcare Map, platform capabilities, and healthcare analytics AI,” said Web Sun, President and Co-Founder, Komodo Health. “Marmot validates our core thesis: When AI is purpose-built for healthcare workflows rather than retrofitted from consumer applications, teams get the speed and transparency they need to drive their business and improve patient outcomes with confidence.”

Industry Validation for Purpose-Built AI

The Forbes Cloud 100, which Komodo has been recognized on five times, represents the definitive ranking of the top 100 private cloud companies globally. TIME’s World’s Top HealthTech Companies highlights companies that deliver the most impactful health technologies. Komodo earned specific recognition in the AI & Data Analytics category with an “Outstanding” performance indicator. The Healthcare Technology Report honors healthcare software companies that are defining the future of healthcare delivery through advanced analytics and AI-driven solutions.

Together, these recognitions underscore Komodo's market-defining approach, as the healthcare industry increasingly demands solutions that balance rapid insights with strict regulatory compliance. Marmot’s healthcare-native design uniquely delivers the analytical rigor and transparency that critical decisions require and positions Komodo to set the industry standard for trustworthy, high-impact insights.

About Komodo Health

Komodo Health is on a mission to reduce the global burden of disease by building foundational AI for how Life Sciences and healthcare organizations discover, develop, and deliver life-saving therapies. The company's healthcare-native AI engine Marmot, powered by the Healthcare Map, eliminates slow, fragmented analyses to accelerate critical healthcare decisions across the product life cycle. For more information, visit www.komodohealth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250930036981/en/

CONTACT: Rowena Kelley

858.405.1971

[email protected]

Real Chemistry for Komodo Health

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: HEALTH TECHNOLOGY SCIENCE HEALTH RESEARCH

SOURCE: Komodo Health

Copyright Business Wire 2025.

PUB: 09/30/2025 09:00 AM/DISC: 09/30/2025 08:59 AM

http://www.businesswire.com/news/home/20250930036981/en